Literature DB >> 11822630

A critique on complementary and alternative medicine.

K I Shine1.   

Abstract

Modern medicine regularly uses the products of science to improve health. Until recently, however, medicine itself has not been practiced in a scientific manner. The growth of evidence-based medicine is predicated upon the concept that insofar as possible, all aspects of medical care ought to be examined with regard to the evidence. All forms of treatments and preventive strategies should be subjected to assessments of efficacy and effectiveness. Efficacy is demonstrated in the day-to-day practice of medicine. An evaluation of effectiveness may lead to one or more randomized clinical trials, where the results of these randomized clinical trials may be necessary to maximize effectiveness. From a health care perspective, safety must be assessed, not only with regard to adverse effects of the particular intervention, but also in the context of a comparison to alternative treatments. If evidence demonstrates the efficacy and/or effectiveness of a particular intervention, it may be unsafe to select a treatment for which evidence of efficacy or effectiveness is lacking. Certainly patients should be fully informed of the evidence that is available for making rational choices. Alternative and complementary modes of medicine should be subject to these principles. The history of digitalis glycosides provides an interesting example of an important treatment arising from herbal medicine, by which many of these elements can be exemplified.

Entities:  

Mesh:

Year:  2001        PMID: 11822630     DOI: 10.1089/107555301753393922

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  2 in total

1.  Which medicine? Whose standard? Critical reflections on medical integration in China.

Authors:  Ruiping Fan; Ian Holliday
Journal:  J Med Ethics       Date:  2007-08       Impact factor: 2.903

2.  Use of mind-body medical therapies.

Authors:  Peter M Wolsko; David M Eisenberg; Roger B Davis; Russell S Phillips
Journal:  J Gen Intern Med       Date:  2004-01       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.